Target intelligence / Profile preview

Gut-associated lymphoid tissue immune cells and pattern-recognition receptors

Molecular classification
Receptor, Other
01

Overview

Gut-associated lymphoid tissue (GALT) represents the largest component of the human immune system and serves as a critical interface between the host and the external environment of the gastrointestinal tract (StatPearls, 2023). It consists of specialized structures like Peyer's patches and isolated lymphoid follicles, which are populated by immune cells such as T cells, B cells, and dendritic cells that coordinate mucosal immunity and maintain tolerance to commensal flora (Nature Reviews Immunology, 2013). Pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), are expressed on these immune cells and intestinal epithelia to sense pathogen-associated molecular patterns (PAMPs) and initiate innate and adaptive immune responses (PubMed, 2021). Dysregulation of GALT immune responses or PRR signaling is a central driver in the pathogenesis of chronic inflammatory conditions like Crohn's disease and ulcerative colitis (Journal of Clinical Investigation, 2017). Therapeutic strategies targeting this system include blocking the homing of lymphocytes to the GALT using integrin inhibitors or modulating specific PRR pathways to restore intestinal homeostasis (Frontiers in Immunology, 2020).

Other names
GALT immune systemIntestinal mucosal immunityGut pattern-recognition receptorsMucosa-associated lymphoid tissue (MALT) of the gastrointestinal tract
02

Mechanism of action

Modulation of mucosal immune responses through cytokine neutralization, inhibition of leukocyte trafficking to the gut (e.g., via integrin antagonism), or activation/antagonism of pattern-recognition receptors to stimulate or suppress innate signaling.

03

Biological functions

Immune responsePathogen recognitionHomeostasisSignal transductionCell trafficking
04

Disease associations

InflammationInfectionAutoimmune diseaseCancerAllergy
05

Safety considerations

Increased susceptibility to enteric infectionsImpaired mucosal healingSystemic immunosuppressionImmunogenicity of therapeutic antibodiesPotential for paradoxical inflammation
06

Interacting drugs

Vedolizumab

6 more in the full profile.

07

Biomarkers

Fecal calprotectinSecretory IgA (sIgA)C-reactive protein (CRP)Alpha-4 beta-7 integrin expression

Beyond the preview

Go deeper on Gut-associated lymphoid tissue immune cells and pattern-recognition receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut-associated lymphoid tissue immune cells and pattern-recognition receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call